The present invention relates to a method for the catalytic conversion in vapor phase of disulfide oil into methane and hydrogen sulfide, comprising the step of contacting disulfide oil, eventually in the presence of water, with a supported transition metal catalyst.

Embodiments of the disclosure provide a system and method for producing a linear alpha olefin. A disulfide, a hydrogen donating compound, and water are combined to produce a mixture. The mixture is introduced to a reactor operated at a pressure equal to or greater than 22.06 MPa and a temperature equal to or greater than 374 deg. C to produce an effluent stream. The effluent stream is separated to produce a product stream including the linear alpha olefin. The disulfide can be a compound of formula R—S—S—R′ where R is a first alkyl group having carbon atoms ranging from 1 to 12 and R′ is a second alkyl group having carbon atoms ranging from 5 to 12. The hydrogen donating compound can include a partially hydrogenated multi-ring aromatic compound.

Embodiments of the disclosure provide a system and method for producing a linear alpha olefin. A disulfide, a hydrogen donating compound, and water are combined to produce a mixture. The mixture is introduced to a reactor operated at a pressure equal to or greater than 22.06 MPa and a temperature equal to or greater than 374 deg. C to produce an effluent stream. The effluent stream is separated to produce a product stream including the linear alpha olefin. The disulfide can be a compound of formula R—S—S—R′ where R is a first alkyl group having carbon atoms ranging from 1 to 12 and R′ is a second alkyl group having carbon atoms ranging from 5 to 12. The hydrogen donating compound can include a partially hydrogenated multi-ring aromatic compound.

A hydrodesulfurization catalyst, which includes (i) a catalyst support including a zeolite doped with 0.1 to 0.5 wt. % of a graphene material, based on a total weight of the catalyst support, (ii) 5 to 20 wt. % of molybdenum, based on a total weight of the hydrodesulfurization catalyst, and (iii) 1 to 6 wt. % of a promoter selected from the group consisting of cobalt and nickel, based on a total weight of the hydrodesulfurization catalyst. The molybdenum and the promoter are homogeneously disposed on the catalyst support. A method of producing the hydrodesulfurization catalyst via incipient wetness impregnation techniques, and a method for desulfurizing a hydrocarbon feedstock with the hydrodesulfurization catalyst are also provided.

Embodiments of the disclosure provide a system and method for producing a linear alpha olefin. A disulfide, a hydrogen donating compound, and water are combined to produce a mixture. The mixture is introduced to a reactor operated at a pressure equal to or greater than 22.06 MPa and a temperature equal to or greater than 374 deg. C. to produce an effluent stream. The effluent stream is separated to produce a product stream including the linear alpha olefin. The disulfide can be a compound of formula R—S—S—R′ where R is a first alkyl group having carbon atoms ranging from 1 to 12 and R′ is a second alkyl group having carbon atoms ranging from 5 to 12. The hydrogen donating compound can include a partially hydrogenated multi-ring aromatic compound.

Embodiments of the disclosure provide a system and method for producing a linear alpha olefin. A disulfide, a hydrogen donating compound, and water are combined to produce a mixture. The mixture is introduced to a reactor operated at a pressure equal to or greater than 22.06 MPa and a temperature equal to or greater than 374 deg. C. to produce an effluent stream. The effluent stream is separated to produce a product stream including the linear alpha olefin. The disulfide can be a compound of formula R—S—S—R′ where R is a first alkyl group having carbon atoms ranging from 1 to 12 and R′ is a second alkyl group having carbon atoms ranging from 5 to 12. The hydrogen donating compound can include a partially hydrogenated multi-ring aromatic compound.

The present disclosure provides methods for preparing polyunsaturated hydrocarbons, such as E,E-farnesol, farnesyl acetate and squalene, by base catalyzed addition of a dialkylamine to a 3-methylene-1-alkene, such as farnesene. The present disclosure also provides compositions including one more farnesene derivatives prepared using the disclosed methods.

A hydrodesulfurization catalyst, which includes (i) a catalyst support including a zeolite doped with 0.1 to 0.5 wt. % of a graphene material, based on a total weight of the catalyst support, (ii) 5 to 20 wt. % of molybdenum, based on a total weight of the hydrodesulfurization catalyst, and (iii) 1 to 6 wt. % of a promoter selected from the group consisting of cobalt and nickel, based on a total weight of the hydrodesulfurization catalyst. The molybdenum and the promoter are homogeneously disposed on the catalyst support. A method of producing the hydrodesulfurization catalyst via incipient wetness impregnation techniques, and a method for desulfurizing a hydrocarbon feedstock with the hydrodesulfurization catalyst are also provided.

Methods for preparing a variety of ladderane precursors, ladderane compounds and ladderane lipids are provided. Also provided are methods of preparing a liposome from the ladderane lipids disclosed herein, and compositions thereof. Aspects of the invention include encapsulated one or more cargo moieties in the liposome or compositions thereof and use of the subject liposome compositions as vehicles in drug delivery, imaging, diagnostics and other medical applications. Aspects of the methods disclosed herein include administering a liposomal composition comprising a pharmaceutical agent to a subject under conditions sufficient to deliver the composition to a site of interest in the subject, and release the pharmaceutical agent from the liposomal composition.

Methods for preparing a variety of ladderane precursors, ladderane compounds and ladderane lipids are provided. Also provided are methods of preparing a liposome from the ladderane lipids disclosed herein, and compositions thereof. Aspects of the invention include encapsulated one or more cargo moieties in the liposome or compositions thereof and use of the subject liposome compositions as vehicles in drug delivery, imaging, diagnostics and other medical applications. Aspects of the methods disclosed herein include administering a liposomal composition comprising a pharmaceutical agent to a subject under conditions sufficient to deliver the composition to a site of interest in the subject, and release the pharmaceutical agent from the liposomal composition.